Tel : +44(0)141 548 5754 (Ext. 5754)
Dr Geoff Coxon is a lecturer in Medicinal Chemistry. After receiving his PhD from the University of Newcastle upon Tyne, and a short term industry, he moved SIPBS where he set up his research group in the discovery and development of new agents to treat tuberculosis. He is the co-founder and Deputy Leader of TB Drug Discovery UK (www.tbd-uk.org.uk). In this role he works with fellow scientists and clinicians, UK government policy makers and advocates with the goal of strengthening scientific research across all areas of TB drug development as a key part of the UK response in the global eradiation of the disease.
"TB Drug Development-UK (TBD-UK)"
Medical Research Council
Bilal Ali Ahmad Al-jaidi: 'Design and Synthesis of Novel Antituberculosis Agents' (started 2007)
Giacomo Berretta: 'the Synthesis of Cyclopropanating Enzymes in Mycolic Acid Biosynthesis Towards New Drug Candidates for the Treatment of Persistant Tuberculosis Infect' (started 2006)
Helena Isabel Pereira Goncalves: 'The identification, design and synthesis of inhibitors of the TpX from Mycobacterium tuberculosis' (started 2011)
John Jeh Lung Tiong: 'Discovery of novel antibacterial and anti-tubercular compounds using chemical genetics and computational approach targeted at phospholipid biosynthesi' (started 2009)